M

Manhattan Medical Research | New York, NY

Research site
(Unclaimed)
Location
215 Lexington Avenue, 21st Floor, New York, New York, United States of America
Site insights

Top conditions

Diabetes Mellitus (8 trials)

Type 2 Diabetes Mellitus (7 trials)

Urinary Bladder Cancer (6 trials)

Non-Muscle Invasive Bladder Cancer (6 trials)

Leiomyoma (5 trials)

Top treatments

Elagolix
UGN-102
LY3298176
Metformin
Estradiol
LY900014
Tirzepatide
IX-01
Norethindrone Acetate
Tradipitant

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

9 of 42
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

This study is being conducted to evaluate the safety and determine the recommended Phase 2 dose (RP2D) of UGN-301 (zalifrelimab) administered intrave...

Enrolling
Carcinoma in Situ of Bladder
Non-muscle Invasive Bladder Cancer
Drug: UGN-201
Drug: Gemcitabine

This Phase 3, multinational, single-arm, multicenter study will evaluate the efficacy and safety of UGN-102 as primary chemoablative therapy in patie...

Active, not recruiting
Bladder Cancer
Urothelial Carcinoma
Drug: UGN-102

This is a Phase Ib/IIb, randomized, two-cohort, open-label, multicenter study of intravesical N-803 plus BCG versus BCG alone, in BCG naïve patients...

Enrolling
Non-muscle Invasive Bladder Cancer
Biological: BCG+N-803
Biological: BCG

The purpose of this study is to demonstrate the efficacy of 9-valent extraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared to placeb...

Enrolling
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
Biological: ExPEC9V
Other: Placebo

The study was performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care

Active, not recruiting
Uterine Fibroids
Drug: Vilaprisan (BAY1002670)
Other: Standard of care

A prospective, multicenter, blind randomized (2:1) controlled study comparing the International Prostate Symptom Score (IPSS) of the Active arm to th...

Enrolling
BPH (Benign Prostatic Hyperplasia)
Lower Urinary Tract Symptoms (LUTS)
Device: Butterfly Prostatic Retraction Device

A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sick...

Enrolling
Motion Sickness
Drug: Placebo
Drug: Tradipitant

This trial is a prospective, multicenter, single-arm study of the safety and effectiveness of eCoinTM tibial nerve stimulation in subjects having ove...

Active, not recruiting
Urinary Urge Incontinence
Incontinence, Urinary
Device: eCoin Tibial Nerve Stimulation

This is a Phase II/III, open-label, single-arm, multicenter study of intravesical BCG plus N-803 or N-803 only in patients with BCG unresponsive high...

Active, not recruiting
Bladder Cancer
Drug: N-803
Drug: N-803 and BCG

Trial sponsors

AbbVie logo

AbbVie (7 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems